![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients |
Hyery Kim, Hyoung Jin Kang, Kyung Duk Park, Kyung-Nam Koh, Ho Joon Im, Jong Jin Seo, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Hack Ki Kim, Jae Min Lee, Jeong Ok Hah, Jun Ah Lee, Young Ho Lee, Sang Kyu Park, Hee Jo Baek, Hoon Kook, Ji Yoon Kim, Heung Sik Kim, Hwang Min Kim, Hee Won Chueh, Meerim Park, Hoi Soo Yoon, Mee Jeong Lee, Hyoung Soo Choi, Hyo Seop Ahn, Yoshifumi Kawano, Ji Won Park, Seokyung Hahn, Hee Young Shin |
Cancer Research and Treatment. 2019;51(1):357-367. Published online 2018 May 14 DOI: https://doi.org/10.4143/crt.2017.457 |
Dexrazoxane for the prevention of cardiomyopathy in anthracycline treated pediatric cancer patients Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: Analysis of a national cohort of patients in the pediatric health information systems database Dengue Fever in Patients With Pediatric Malignancy on Chemotherapy: A Concern in Tropical Countries Radiation treatment of patients with primary pediatric malignancies: risk of developing thyroid cancer as a secondary malignancy Increased Risk of Second Primary Malignancy in Pediatric and Young Adult Patients Treated with Radioactive Iodine for Differentiated Thyroid Cancer Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane Reply to Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane PB1714: DEXRAZOXANE IN HAEMATOLOGICAL PATIENTS: A META-ANALYSIS OF THE CARDIOPROTECTIVE EFFICACY, RISK OF SECONDARY MALIGNANCIES AND IMPACT IN SURVIVAL OUTCOMES |
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014. |